Image 1
Dicyclomine Hydrochloride Tablet
Product Images NDC 0591-0795
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dicyclomine Hydrochloride (NDC 0591-0795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a prescription drug with the National Drug Code (NDC) 0591-0794-01 used to manage symptoms of irritable bowel syndrome. The drug is in the form of capsules with 10 mg of Dicyclomine hydrochloride USP in each capsule. To obtain full prescribing information, the package outsert should be consulted. The drug should be kept in a well-closed container at 20°-25°C (68°-77°F) to maintain its effectiveness. Teva Pharmaceuticals USA, Inc. also produced the drug.*
Image 3
This is a description of a prescription drug named Dicyclomine Hydrochloride Tablets, USP. The tablets are only available through a prescription and each tablet contains 20 mg of Dicyclomine hydrochloride USP. The package includes 100 tablets and the recommended dosage can be found in the package outsert. The tablets should be kept in a well-closed container at a temperature between 20°C-25°C (68°-77°F). The drug should be kept out of the reach of children. The drug is manufactured by Teva Pharmaceuticals USA, Inc. The text includes some product details, such as the National Drug Code (NDC) and a serialization coding area.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
